IRIS
MADEDDU, Denise
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.794
EU - Europa 2.025
AS - Asia 1.988
SA - Sud America 286
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 7.180
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.724
SG - Singapore 750
CN - Cina 732
IT - Italia 458
SE - Svezia 361
IE - Irlanda 354
BR - Brasile 236
FI - Finlandia 214
DE - Germania 212
HK - Hong Kong 170
VN - Vietnam 107
TR - Turchia 73
FR - Francia 64
NL - Olanda 64
ZA - Sudafrica 61
GB - Regno Unito 58
AT - Austria 55
IN - India 45
CA - Canada 44
BE - Belgio 40
UA - Ucraina 39
BD - Bangladesh 28
CZ - Repubblica Ceca 27
RU - Federazione Russa 20
PL - Polonia 19
MX - Messico 18
AR - Argentina 15
IQ - Iraq 15
JP - Giappone 15
LT - Lituania 13
EC - Ecuador 12
CI - Costa d'Avorio 10
ID - Indonesia 9
PK - Pakistan 9
UZ - Uzbekistan 8
CO - Colombia 7
ES - Italia 6
MA - Marocco 6
RO - Romania 6
VE - Venezuela 6
JO - Giordania 5
AZ - Azerbaigian 4
CH - Svizzera 4
OM - Oman 3
UY - Uruguay 3
AU - Australia 2
BO - Bolivia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.180
Salva come PNG Salva come JPEG
Città #
Singapore 408
Chandler 395
Dublin 354
Ashburn 344
Dallas 207
Ann Arbor 186
Parma 181
Hong Kong 167
Santa Clara 163
Beijing 160
Boardman 118
Dearborn 112
New York 90
Shanghai 81
Munich 76
Nanjing 76
Los Angeles 59
Johannesburg 58
Izmir 57
Padova 57
Princeton 54
Bremen 49
Vienna 48
Wilmington 45
Jacksonville 43
Helsinki 42
Brussels 40
Ho Chi Minh City 38
Nanchang 31
Jinan 28
Buffalo 25
São Paulo 25
Hebei 24
Hanoi 22
Columbus 21
Seattle 21
Brooklyn 18
San Mateo 18
Hefei 17
London 17
Pune 17
Shenyang 17
Des Moines 16
Guangzhou 16
Jiaxing 16
Kunming 16
Rio Saliceto 16
Toronto 16
Turku 16
Warsaw 15
Milan 14
Changsha 13
Fremont 13
Norwalk 13
Brno 12
Moscow 12
Tokyo 12
Zhengzhou 12
Frankfurt am Main 11
The Dalles 11
Tianjin 11
Abidjan 10
Denver 10
Houston 10
Nuremberg 10
Redmond 10
Stockholm 10
Tulsa 10
Hangzhou 9
Woodbridge 9
Chennai 8
Haiphong 8
Modena 8
Montreal 8
Olomouc 8
Rio de Janeiro 8
Boston 7
Falkenstein 7
Jakarta 7
Atlanta 6
Falls Church 6
Guayaquil 6
Haikou 6
Kocaeli 6
Marseille 6
Mexico City 6
Phoenix 6
Redwood City 6
Amman 5
Amsterdam 5
Baghdad 5
Campinas 5
Contagem 5
Council Bluffs 5
Curitiba 5
Dhaka 5
Genova 5
Ottawa 5
Redondo Beach 5
Rome 5
Totale 4.541
Salva come PNG Salva come JPEG
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 239
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 183
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 183
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 181
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 170
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 168
Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism. 164
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells. 163
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 162
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 157
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 157
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 156
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 153
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 151
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 149
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 147
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 146
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines 145
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 140
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 138
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 138
Potential involvement of cardiac and bone marrow vascular progenitors in imatinib induced cardiovascular toxicity 137
Assessment of Cardiac Patches Suitability for Tissue Engineering 137
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 137
Isolation and characterization of human lung lymphatic endothelial cells 135
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 132
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 132
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 131
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 130
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 129
Resident cardiac stem cells. 125
Stem cells and myocardial regeneration 125
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 125
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 124
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 123
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 119
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 118
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 116
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 110
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 110
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 107
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 107
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 105
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application 101
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 97
LUNG MESENCHYMAL STEM CELLS FUNCTION AS THE INDUCTIVE MICROENVIRONMENT FOR HUMAN LUNG CANCER PROPAGATING CELLS 97
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 97
IGF-1 loaded injectable microspheres for potential repair of the infarcted myocardium 96
Correction: A versatile bioreactor for dynamic suspension cell culture. Application to the culture of cancer cell spheroids 91
Low vagally-mediated heart rate variability and increased susceptibility to ventricular arrhythmias in rats bred for high anxiety. 88
Influence of injectable microparticle size on cardiac progenitor cell response 86
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells 85
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 82
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 76
Reinforced alginate/gelatin sponges functionalized by avidin/biotin-binding strategy: a novel cardiac patch 75
In vitro suspension bioreactor-based platform for culturing tumor cell clusters 72
Thermoreversible injectable polyurethane hydrogels: future challenges for biomedical applications 62
Totale 7.309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.158
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 29 21 31 51 25 55 18
2021/2022273 17 11 9 14 4 10 39 21 12 21 11 104
2022/20231.524 160 186 102 121 160 156 37 81 428 10 69 14
2023/2024566 22 41 8 16 50 152 51 24 17 46 66 73
2024/20251.418 29 71 102 114 164 125 82 71 134 121 139 266
2025/20261.784 334 256 366 295 447 86 0 0 0 0 0 0
Totale 7.309